Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKazatomprom S Regulatory News (KAP)

Share Price Information for Kazatomprom S (KAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.75
Bid: 40.05
Ask: 45.95
Change: 0.00 (0.00%)
Spread: 5.90 (14.732%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 40.75
KAP Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID19 Current Situation and Implications for KAP

16 Mar 2020 07:26

RNS Number : 2369G
JSC National Atomic Co. Kazatomprom
16 March 2020
 

AIX: KAP, KAP.Y (GDR)

LSE: KAP (GDR)

Currency: KZT (₸), unless otherwise noted

 

 

16 March 2020, Nur-Sultan, Kazakhstan

 

COVID-19: Current Situation and Implications for KAP

JSC National Atomic Company "Kazatomprom" ("Kazatomprom" or "the Company") announces the following update related to the impact of the COVID-19 outbreak on the Company, including the measures taken to date and possible future implications to its business.

The World Health Organization has elevated the COVID-19 outbreak to the level of pandemic and following the confirmation of the first cases of the disease in Kazakhstan on 15 March 2020 the President of the Republic of Kazakhstan, Kassym-Jomart Tokayev, declared a country-wide state of emergency. The President's decree is expected to remain in effect from 16 March 2020 until 15 April 2020, with full details available on the following government website: https://www.akorda.kz/ru/legal_acts/decrees/o-vvedenii-chrezvychainogo-polozheniya-v-respublike-kazahstan

"The coronavirus outbreak is first and foremost a global human emergency, affecting hundreds of thousands of people," said Galymzhan Pirmatov, Chief Executive Officer of the Company, "and as it continues to expand, it will undoubtedly have a growing impact on businesses and world economies. However, the current priority for Kazatomprom is the health and safety of our people. We have assembled a cross-functional committee to continuously monitor the situation and have immediately taken actions to protect our employees and their families. Strict preventive measures are now in place, including the transfer of certain higher risk groups of employees to remote work schedules, implementing rotating remote work schedule and limiting all travels and direct contact where possible. As of today, we remain committed to our 2020 production and sales plans, but the situation is changing rapidly, and we are preparing for various scenarios accordingly."

Kazatomprom's uranium mining sites are primarily in remote areas of the South regions of Kazakhstan, and to date, the pandemic has had no impact on the Company's uranium mining or processing operations. However, their remote nature requires that production, maintenance, catering and support staff stay on site and live in close quarters while at work. COVID-19 could pose a significant health and safety concern if an outbreak were to occur in such a setting, and/or if key staff were restricted to quarantine and unable to work. As a result, in addition to the initial measures already taken to minimize the spread of COVID-19, the Company is assessing various production and delivery scenarios. Kazatomprom will not hesitate to take any actions necessary to keep people safe, ensure the environment is protected and our assets are properly managed during this global pandemic. Actions taken could result in lower production due to pre-emptive suspensions of one or more operations.

In the event that mine production or the ability to physically deliver material is impacted, Kazatomprom's production decisions and contractual obligations are backed by inventory, and the Company will continue to responsibly manage its supply sources in order to meet the commitments. At 31 December 2019, the Company had over 8,500 tU of inventory on attributable basis, equal to approximately eight months of 2020 attributable production.

Kazatomprom will keep stakeholders updated regarding any changes and/or effects on the Company's businesses and operations related to COVID-19.

For further information, please contact:

Kazatomprom Investor Relations Inquiries

Cory Kos, Director of Investor and Public Relations

Tel: +7 (8) 7172 45 81 80

Email: ir@kazatomprom.kz

 

Kazatomprom Public Relations and Media Inquiries

Torgyn Mukayeva, Deputy Director of Investor and Public Relations

Tel: +7 (8) 7172 45 80 63

Email: pr@kazatomprom.kz 

Powerscourt - London (Giles Read)

Tel: +44 20 7250 1446

Email: Kazatomprom@powerscourt-group.com

A copy of this announcement will be made available at www.kazatomprom.kz.

About Kazatomprom

Kazatomprom is the world's largest producer of uranium, with the company's attributable production representing approximately 24% of global primary uranium production in 2019. The Group benefits from the largest reserve base in the industry and operates, through its subsidiaries, JVs and Associates, 24 deposits grouped into 13 mining assets. All of the Company's mining operations are located in Kazakhstan and mined using ISR technology with a focus on maintaining industry-leading health, safety and environment standards.

Kazatomprom securities are listed on the London Stock Exchange and Astana International Exchange. As the national atomic company in the Republic of Kazakhstan, the Group's primary customers are operators of nuclear generation capacity, and the principal export markets for the Group's products are China, South and Eastern Asia, Europe and North America. The Group sells uranium and uranium products under long-term contracts, short-term contracts, as well as in the spot market, directly from its headquarters in Nur-Sultan, Kazakhstan, and through its Switzerland-based trading subsidiary, Trade House KazakAtom AG (THK).For more information, please see our newly updated website at http://www.kazatomprom.kz

Forward-looking statements

All statements other than statements of historical fact included in this communication or document are forward-looking statements. Forward-looking statements give the Company's current expectations and projections relating to its financial condition, results of operations, plans, objectives, future performance and business. These statements may include, without limitation, any statements preceded by, followed by or including words such as "target," "believe," "expect," "aim," "intend," "may," "anticipate," "estimate," "plan," "project," "will," "can have," "likely," "should," "would," "could" and other words and terms of similar meaning or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company's control that could cause the Company's actual results, performance or achievements to be materially different from the expected results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which it will operate in the future. THE INFORMATION WITH RESPECT TO ANY PROJECTIONS PRESENTED HEREIN IS BASED ON A NUMBER OF ASSUMPTIONS ABOUT FUTURE EVENTS AND IS SUBJECT TO SIGNIFICANT ECONOMIC AND COMPETITIVE UNCERTAINTY AND OTHER CONTINGENCIES, NONE OF WHICH CAN BE PREDICTED WITH ANY CERTAINTY AND SOME OF WHICH ARE BEYOND THE CONTROL OF THE COMPANY. THERE CAN BE NO ASSURANCES THAT THE PROJECTIONS WILL BE REALISED, AND ACTUAL RESULTS MAY BE HIGHER OR LOWER THAN THOSE INDICATED. NONE OF THE COMPANY NOR ITS SHAREHOLDERS, DIRECTORS, OFFICERS, EMPLOYEES, ADVISORS OR AFFILIATES, OR ANY REPRESENTATIVES OR AFFILIATES OF THE FOREGOING, ASSUMES RESPONSIBILITY FOR THE ACCURACY OF THE PROJECTIONS PRESENTED HEREIN. The information contained in this communication or document, including but not limited to forward-looking statements, applies only as of the date hereof and is not intended to give any assurances as to future results. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to such information, including any financial data or forward-looking statements, and will not publicly release any revisions it may make to the Information that may result from any change in the Company's expectations, any change in events, conditions or circumstances on which these forward-looking statements are based, or other events or circumstances arising after the date hereof.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCEAXDKFAAEEEA
Date   Source Headline
16th Mar 20217:00 amRNSKazatomprom 2020 Financial Results
10th Mar 20217:00 amRNSKazatomprom Announces Management Change
1st Mar 20217:18 amRNSKazatomprom 2020 FY Results and Conference Call
1st Feb 20218:03 amRNSKazatomprom 4Q20 Operations and Trading Update
22nd Jan 20219:33 amRNSConfirmed COVID-19 Case Count for KATCO JV
20th Jan 202112:25 pmRNSCOVID-19 Cases at KATCO JV
29th Dec 20207:00 amRNSKazatomprom-CGNPC Cooperation Agreement Update
27th Nov 20207:00 amRNS9M 2020 Financials News Release
10th Nov 20207:34 amRNSKazatomprom Announces Management Changes
2nd Nov 20207:00 amRNSKazatomprom 3Q20 Operations and Trading Update
27th Aug 20207:00 amRNSKazatomprom 1H20 Financial Results
19th Aug 20207:00 amRNSKazatomprom Announces 2022 Production Plans
3rd Aug 20207:00 amRNSKazatomprom 2Q20 Operations and Trading Update
29th Jul 20207:00 amRNSEGM Voting Results
6th Jul 20207:00 amRNSCOVID-19: Update on Kazatomprom Operations
25th Jun 20207:02 amRNSReport on Payments to Governments
10th Jun 20202:52 pmRNSCompletion of Offering in NAC Kazatomprom
5th Jun 20206:20 pmRNSCompletion of the Inst. Placing in NAC Kazatomprom
4th Jun 20207:00 amRNSNotice of Kazatomprom’s EGM of Shareholders
3rd Jun 20204:18 pmRNSKazatomprom Responds to Secondary Offering
3rd Jun 202010:19 amRNSResults of inst. placing in NAC Kazatomprom
2nd Jun 20205:11 pmRNSPlacing of shares in NAC Kazatomprom JSC
21st May 20207:00 amRNSKazatomprom 1Q20 Consolidated Financial Statements
19th May 20207:00 amRNSAnnual General Meeting of Shareholders Results
5th May 20207:17 amRNSKazatomprom signs contract with Dioxitek
4th May 20207:00 amRNSKazatomprom 1Q20 Operations and Trading Update
30th Apr 202012:12 pmRNS2019 Integrated Annual Report - Replacement
30th Apr 202011:16 amRNS2019 Integrated Annual Report
17th Apr 202012:38 pmRNSNotice of AGM, 2019 Dividend, Annual Report
7th Apr 20207:00 amRNSCOVID-19: Update on Kazatomprom Operations
20th Mar 20204:42 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Mar 202012:07 pmRNSSecond Price Monitoring Extn
20th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20209:30 amRNSKazatomprom completes sale of UEC interest
16th Mar 20207:26 amRNSCOVID19 Current Situation and Implications for KAP
5th Mar 20207:00 amRNSKazatomprom 2019 Financial Results
20th Feb 20207:00 amRNSAppointment of Board Committee Chairpersons of KAP
3rd Feb 20207:00 amRNSKazatomprom 4Q19 Operations and Trading Update
30th Jan 20204:48 pmRNSIntention to Sell Interest in UEC
6th Dec 201912:10 pmRNSKazatomprom Announces Change in Board of Directors
4th Dec 20197:00 amRNSEGM Results
28th Nov 20197:00 amRNS3rd Quarter Results
1st Nov 20197:00 amRNSKazatomprom 3Q19 Operations and Trading Update
17th Oct 20197:00 amRNSKAP's EGM notice
8th Oct 20197:00 amRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSPlacement of bonds of NAC Kazatomprom JSC
26th Sep 201912:47 pmRNSKazatomprom responds to secondary offering
26th Sep 20197:52 amRNSSamruk Kazyna Announces Results of GDRs Placement
25th Sep 20194:48 pmRNSSamruk Kazyna announces intention to sell GDRs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.